24 related articles for article (PubMed ID: 16204938)
1. Properties, Pharmacology, and Pharmacokinetics of Active Indole and Oxindole Alkaloids in
Kushida H; Matsumoto T; Ikarashi Y
Front Pharmacol; 2021; 12():688670. PubMed ID: 34335255
[No Abstract] [Full Text] [Related]
2. Cognitive Dysfunction in a Mouse Model of Cerebral Ischemia Influences Salivary Metabolomics.
To M; Sugimoto M; Saruta J; Yamamoto Y; Sakaguchi W; Kawata A; Matsuo M; Tsukinoki K
J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33920851
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide improves sevoflurane-induced cognitive impairment through suppression of inflammation and anti-apoptosis in rat.
Wang Y; Zuo M
Int J Clin Exp Med; 2015; 8(11):20079-85. PubMed ID: 26884920
[TBL] [Abstract][Full Text] [Related]
4. Astaxanthin improves cognitive deficits from oxidative stress, nitric oxide synthase and inflammation through upregulation of PI3K/Akt in diabetes rat.
Xu L; Zhu J; Yin W; Ding X
Int J Clin Exp Pathol; 2015; 8(6):6083-94. PubMed ID: 26261486
[TBL] [Abstract][Full Text] [Related]
5. Sigma 1 receptor activation regulates brain-derived neurotrophic factor through NR2A-CaMKIV-TORC1 pathway to rescue the impairment of learning and memory induced by brain ischaemia/reperfusion.
Xu Q; Ji XF; Chi TY; Liu P; Jin G; Gu SL; Zou LB
Psychopharmacology (Berl); 2015 May; 232(10):1779-91. PubMed ID: 25420607
[TBL] [Abstract][Full Text] [Related]
6. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety.
File SE; Kenny PJ; Cheeta S
Pharmacol Biochem Behav; 2000 May; 66(1):65-72. PubMed ID: 10837844
[TBL] [Abstract][Full Text] [Related]
7. Kampo formulations, chotosan, and yokukansan, for dementia therapy: existing clinical and preclinical evidence.
Matsumoto K; Zhao Q; Niu Y; Fujiwara H; Tanaka K; Sasaki-Hamada S; Oka J
J Pharmacol Sci; 2013; 122(4):257-69. PubMed ID: 23883485
[TBL] [Abstract][Full Text] [Related]
8. Choto-san, a Kampo formula, improves chronic cerebral hypoperfusion-induced spatial learning deficit via stimulation of muscarinic M1 receptor.
Murakami Y; Zhao Q; Harada K; Tohda M; Watanabe H; Matsumoto K
Pharmacol Biochem Behav; 2005 Jul; 81(3):616-25. PubMed ID: 15936808
[TBL] [Abstract][Full Text] [Related]
9. Ameliorative effect of tacrine on spatial memory deficit in chronic two-vessel occluded rats is reversible and mediated by muscarinic M1 receptor stimulation.
Murakami Y; Ikenoya M; Matsumoto K; Li H; Watanabe H
Behav Brain Res; 2000 Apr; 109(1):83-90. PubMed ID: 10699660
[TBL] [Abstract][Full Text] [Related]
10. Chotosan, a kampo formula, ameliorates chronic cerebral hypoperfusion-induced deficits in object recognition behaviors and central cholinergic systems in mice.
Zhao Q; Murakami Y; Tohda M; Obi R; Shimada Y; Matsumoto K
J Pharmacol Sci; 2007 Apr; 103(4):360-73. PubMed ID: 17409635
[TBL] [Abstract][Full Text] [Related]
11. Chotosan (Diaoteng San)-induced improvement of cognitive deficits in senescence-accelerated mouse (SAMP8) involves the amelioration of angiogenic/neurotrophic factors and neuroplasticity systems in the brain.
Zhao Q; Yokozawa T; Tsuneyama K; Tanaka K; Miyata T; Shibahara N; Matsumoto K
Chin Med; 2011 Sep; 6():33. PubMed ID: 21943225
[TBL] [Abstract][Full Text] [Related]
12. Chotosan improves Aβ1-42-induced cognitive impairment and neuroinflammatory and apoptotic responses through the inhibition of TLR-4/NF-κB signaling in mice.
Chen L; Hu L; Zhao J; Hong H; Feng F; Qu W; Liu W
J Ethnopharmacol; 2016 Sep; 191():398-407. PubMed ID: 26994819
[TBL] [Abstract][Full Text] [Related]
13. Preventive effect of chotosan, a Kampo medicine, on transient ischemia-induced learning deficit is mediated by stimulation of muscarinic M1 but not nicotinic receptor.
Zhao Q; Murakami Y; Tohda M; Watanabe H; Matsumoto K
Biol Pharm Bull; 2005 Oct; 28(10):1873-8. PubMed ID: 16204938
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
